Biofrontera Inc. (BFRI) Financials
BFRI Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 27.9 million | 23.1 million |
2023-09-30 | 34.1 million | 33.1 million |
2023-06-30 | 36.9 million | 29.7 million |
2023-03-31 | 42.0 million | 25.2 million |
BFRI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -8.9 million | 228000 |
2023-09-30 | -2.0 million | 207000 |
2023-06-30 | -10.3 million | 259000 |
2023-03-31 | -3.7 million | 351000 |
BFRI Net Income
No data available :(
BFRI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.4 million | - | 1.5 million |
2023-09-30 | 6.8 million | - | 1.1 million |
2023-06-30 | 10.4 million | - | 1.1 million |
2023-03-31 | 21.1 million | - | 1.2 million |
BFRI Shares Outstanding
BFRI Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 9000 | 33000 | 9.1 million | -295000 |
2023-09-30 | - | 33000 | 8.7 million | -74000 |
2023-06-30 | - | 11000 | 11.5 million | - |
2023-03-31 | 14000 | - | 9.8 million | - |
BFRI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 10.6 million | 5.7 million |
2023-09-30 | 8.9 million | 4.5 million |
2023-06-30 | 5.8 million | 2.9 million |
2023-03-31 | 8.7 million | 4.6 million |
BFRI
Price: $1.79
52 week price:
Earnings Per Share: -13.02 USD
P/E Ratio: -0.03
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 345400
Market Capitalization: 9.3 million